CMA
64
5
SYF
71
6
SWN
73
3
CAG
36
-3
SCHW
49
4
O
28
-7
DOV
69
6
CAT
69
7
INTU
65
5
MHK
55
12
JNJ
47
-4
AON
56
-4
CMG
54
4
CSX
64
4
TROW
39
4
PFG
59
6
GRMN
52
2
NDAQ
63
4
WAT
52
3
MCD
65
2
CMA
64
5
SYF
71
6
SWN
73
3
CAG
36
-3
SCHW
49
4
O
28
-7
DOV
69
6
CAT
69
7
INTU
65
5
MHK
55
12
JNJ
47
-4
AON
56
-4
CMG
54
4
CSX
64
4
TROW
39
4
PFG
59
6
GRMN
52
2
NDAQ
63
4
WAT
52
3
MCD
65
2
Financhill
Back

Cellectar Biosciences Vs. Marinus Pharmaceuticals Industry Stock Comparison

Sell
44

CLRB
Cellectar Biosciences

Last Price:
2.06
Seasonality Move:
-15.64%
Sell
50

MRNS
Marinus Pharmaceuticals

Last Price:
1.60
Seasonality Move:
6.86%
Sell
44
Cellectar Biosciences (CLRB) is a Sell

Is Cellectar Biosciences a Buy, Sell or Hold?

  • The current Cellectar Biosciences [CLRB] share price is $2.11. The Score for CLRB is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • CLRB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
Marinus Pharmaceuticals (MRNS) is a Sell

Is Marinus Pharmaceuticals a Buy, Sell or Hold?

  • The current Marinus Pharmaceuticals [MRNS] share price is $1.61. The Score for MRNS is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • MRNS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CLRB Stock Price Chart

What is Cellectar Biosciences's stock price today?

  • The Cellectar Biosciences share price today is $2.11
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLRB is experiencing selling pressure, which indicates risk of future bearish movement.

MRNS Stock Price Chart

What is Marinus Pharmaceuticals's stock price today?

  • The Marinus Pharmaceuticals share price today is $1.61
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MRNS is experiencing buying pressure, which is a positive indicator for future bullish movement.

CLRB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 47.36 Sell
Chaikin Money Flow: -173871 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.07 - 2.17) Sell
Bollinger Bands (100): (2.1 - 3.08) Sell

MRNS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.06 Buy
Relative Strength Index (14 RSI): 67.45 Buy
Chaikin Money Flow: 293553 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.32 - 1.5) Buy
Bollinger Bands (100): (1.27 - 1.49) Buy

CLRB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.11 Buy
20-day SMA: 2.13 Sell
50-day SMA: 2.19 Sell
200-day SMA: 2.99 Sell
8-day EMA: 2.11 Buy
20-day EMA: 2.12 Sell
50-day EMA: 2.24 Sell
200-day EMA: 2.67 Sell

MRNS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.49 Buy
20-day SMA: 1.44 Buy
50-day SMA: 1.37 Buy
200-day SMA: 5.01 Sell
8-day EMA: 1.51 Buy
20-day EMA: 1.45 Buy
50-day EMA: 1.49 Buy
200-day EMA: 3.77 Sell

Cellectar Biosciences Earnings Growth & CLRB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.07 per share, an increase next quarter of $0.02 per share, an increase this year of $1.08 per share, and an increase next year of $1.21 per share.

Marinus Pharmaceuticals Earnings Growth & MRNS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.24 per share, an increase next quarter of $0.21 per share, an increase this year of $0.63 per share, and an increase next year of $0.90 per share.

Cellectar Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Marinus Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):